116 related articles for article (PubMed ID: 10500777)
41. Comparison between anthracyclines and rhodamine-123 accumulation in chronic lymphoid leukemia: effect of cyclosporin A and verapamil.
Maia RC; Vasconcelos FC; Harab RC; Coelho AM; Dobbin JA; Rumjanek VM
Tumour Biol; 1998; 19(1):41-51. PubMed ID: 9422081
[TBL] [Abstract][Full Text] [Related]
42. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI
Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524
[TBL] [Abstract][Full Text] [Related]
43. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
Winfield DA; Polacarz SV
J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
[No Abstract] [Full Text] [Related]
44. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
Gronda M; Malka A; Demattei A; Elizalde P; Santarelli MT; Bianchi de Di Risio CC
Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
[No Abstract] [Full Text] [Related]
45. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome.
Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M
Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636
[TBL] [Abstract][Full Text] [Related]
46. Reversion of P-glycoprotein-mediated multidrug resistance in human leukemic cell line by carnosic acid.
Yu XN; Chen XL; Li H; Li XX; Li HQ; Jin WR
Chin J Physiol; 2008 Dec; 51(6):348-56. PubMed ID: 19280878
[TBL] [Abstract][Full Text] [Related]
47. Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts.
Sonneveld P; Wiemer E
Leukemia; 1997 Jul; 11(7):1160-5. PubMed ID: 9205006
[TBL] [Abstract][Full Text] [Related]
48. Rhodamine 123 efflux modulation in the presence of low or high serum from CD56+ hematopoietic cells or CD34+ leukemic blasts by B9309-068, a newly designed pyridine derivative.
Beck JF; Buchholz F; Ulrich WR; Boer R; Sanders KH; Niethammer D; Gekeler V
Cancer Lett; 1998 Jul; 129(2):157-63. PubMed ID: 9719457
[TBL] [Abstract][Full Text] [Related]
49. Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia.
Swerts K; de Moerloose B; Dhooge C; Noens L; Laureys G; Benoit Y; Philippé J
Leuk Lymphoma; 2004 Nov; 45(11):2221-8. PubMed ID: 15512810
[TBL] [Abstract][Full Text] [Related]
50. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
Wang YH; Imai Y; Shiseki M; Tanaka J; Motoji T
Leuk Res; 2018 Apr; 67():99-108. PubMed ID: 29482174
[TBL] [Abstract][Full Text] [Related]
51. Apoptosis by anthracyclines at therapeutic concentrations in MDR1+ human leukemic cells.
Chiodini B; Bassan R; Barbui T
Adv Exp Med Biol; 1999; 457():313-24. PubMed ID: 10500807
[TBL] [Abstract][Full Text] [Related]
52. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.
Hu XF; Slater A; Wall DM; Kantharidis P; Parkin JD; Cowman A; Zalcberg JR
Br J Cancer; 1995 May; 71(5):931-6. PubMed ID: 7734315
[TBL] [Abstract][Full Text] [Related]
53. Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin.
Borska S; Sopel M; Chmielewska M; Zabel M; Dziegiel P
Molecules; 2010 Feb; 15(2):857-70. PubMed ID: 20335952
[TBL] [Abstract][Full Text] [Related]
54. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
55. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
56. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9.
Dash AB; Williams IR; Kutok JL; Tomasson MH; Anastasiadou E; Lindahl K; Li S; Van Etten RA; Borrow J; Housman D; Druker B; Gilliland DG
Proc Natl Acad Sci U S A; 2002 May; 99(11):7622-7. PubMed ID: 12032333
[TBL] [Abstract][Full Text] [Related]
57. Reproducible measurements of AML blast p-glycoprotein function in 2 center analyses.
Pallis M; Fisher J; Truran L; Grundy M; Russell N; Burnett A
Blood; 2005 Feb; 105(3):1367-8. PubMed ID: 15659619
[No Abstract] [Full Text] [Related]
58. In vitro effect of P-glycoprotein (P-gp) modulators on drug sensitivity of leukemic progenitors (CFU-L) in acute myelogenous leukemia (AML).
Marie JP; Helou C; Thevenin D; Delmer A; Zittoun R
Exp Hematol; 1992 Jun; 20(5):565-8. PubMed ID: 1350249
[TBL] [Abstract][Full Text] [Related]
59. An in vitro study of blast cell metabolism in acute myeloid leukaemia using the MTT assay.
Elgie AW; Sargent JM; Taylor CG; Williamson C
Leuk Res; 1996 May; 20(5):407-13. PubMed ID: 8683980
[TBL] [Abstract][Full Text] [Related]
60. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW
Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
